Boehringer Ingelheim Korea named Mr. Reinke as CEO.

Published: 2005-12-22 06:59:00

Updated: 2005-12-22 06:59:00

Former vice president, Guenter Reinke of Boehringer Ingelheim Korea (BIK) has promoted to the CEO as of Dec. 17 taking an official effect from Jan. 1 next year.

He was born in 1951 and started his business career at Boehringer Ingelheim in 1980 after having graduated from Hagenen Dortmunt Un...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK